Lab Results
Omega-3 Index: The Single Best Cardiovascular Risk Marker You Can Move
Most people track cholesterol, yet research consistently shows the omega-3 index — a simple measure of EPA and DHA in your red blood cells — predicts sudden cardiac death better than LDL. Fewer than 1 in 30 Americans sit in the optimal zone. Here's how to find out where you stand and exactly what to do about it.
Why Your Omega-3 Index Matters More Than You Think
Cardiovascular disease kills more Americans each year than all cancers combined, yet one of the most powerful biomarkers for predicting — and preventing — it rarely appears on a standard lipid panel. The omega-3 index measures the percentage of EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) in your red blood cell membranes relative to total fatty acids. Because red blood cells turn over roughly every 90–120 days, the test gives a stable, time-averaged picture of your long-term omega-3 status — far more meaningful than a single dietary recall.
The statistic that should make everyone pay attention: studies from the Framingham Heart Study cohort found that individuals in the lowest omega-3 index quartile had more than a twofold higher risk of all-cause mortality compared to those in the highest quartile (Harris et al., Journal of the American Heart Association 2021; PMID: 33719519). And the majority of U.S. adults sit in that low-risk zone — for the wrong reasons.
Understanding your omega-3 index optimal target, how to test it accurately, and how to move the number with evidence-based supplementation is one of the highest-yield investments you can make in preventive health.
---
What Is the Omega-3 Index Target? Understanding the Reference Ranges
The omega-3 index was formally developed and validated as a risk factor for heart disease in the early 2000s. The research framework established three clinically meaningful zones:
| Omega-3 Index | Cardiovascular Risk Category | Estimated Prevalence in U.S. Adults |
|---|---|---|
| < 4% | High risk | ~20–25% |
| 4–8% | Intermediate risk | ~65–70% |
| 8–12% | Low / Optimal risk | ~5–8% |
| > 12% | Optimal+ (mainly found in Japan, Greenland) | < 2% in U.S. |
The 8% threshold is not arbitrary. A landmark paper by Harris and Von Schacky proposed that an index of 8% or above is associated with the greatest protection against fatal coronary artery disease, while an index below 4% roughly triples the relative risk (Harris & Von Schacky, Preventive Medicine 2004; PMID: 15208005). Reaching and sustaining above 8% — ideally toward 10–12% — is the actionable goal for most adults.
Notably, the omega-3 index correlates poorly with dietary fish intake surveys, which is one reason it needs to be measured directly. Genetics (specifically variants in the FADS1 and FADS2 genes that regulate fatty acid conversion), body mass index, smoking status, and baseline dietary patterns all influence the final number in ways that make self-estimation unreliable.
---
The EPA DHA Blood Test: How Omega-3 Index Testing Works
An EPA DHA blood test that measures the omega-3 index is distinct from a standard serum fatty acid panel. The key technical difference: the omega-3 index specifically measures EPA + DHA as a percentage of total fatty acids in the red blood cell phospholipid membrane, not in serum or plasma. Membrane composition reflects chronic status; plasma levels fluctuate hour-to-hour based on recent intake.
The test typically requires a small dried blood spot (DBS) collected via fingerstick, which makes it convenient for at-home collection. Results are reported as a percentage and are generally reproducible within ±1% when using a standardized laboratory method.
What the test reports:
- Omega-3 index (EPA + DHA %)
- Trans fat index (a bonus cardiovascular risk marker)
- Omega-6:omega-3 ratio
- AA:EPA ratio (important for inflammatory balance)
For meaningful interpretation, you want to test in the morning before taking any fish oil supplements that day. A single capsule taken an hour before the draw can temporarily elevate plasma levels without reflecting true tissue status, though with the DBS/RBC method the effect is far smaller than with plasma-based tests.
If you're working with a platform that analyzes your lab data — like Ones, which ingests blood work alongside wearable metrics to build a personalized formula — providing your omega-3 index result (rather than just dietary questionnaire data) gives the AI far more precise dosing information.
---
Bill Harris, Omega-3, and the Science Behind the Index
No discussion of the omega-3 index is complete without acknowledging the foundational work of Dr. William S. (Bill) Harris, a professor at the University of South Dakota and founder of OmegaQuant Analytics. Harris has published over 350 peer-reviewed papers on omega-3 fatty acids and is widely considered the architect of the omega-3 index as a clinical biomarker.
The 2004 Harris & Von Schacky paper in Preventive Medicine (PMID: 15208005) is the foundational publication that proposed the omega-3 index as a modifiable risk factor for cardiovascular death. Harris subsequently helped develop and standardize the OmegaQuant laboratory method that became the reference standard used in most major clinical trials.
One of Harris's critical contributions was demonstrating that the form of omega-3 you consume matters significantly for raising the index. Specifically:
- Ethyl ester (EE) fish oil (the most common pharmaceutical and supplement form) raises the omega-3 index less efficiently than re-esterified triglyceride (rTG) or natural triglyceride (nTG) forms, particularly when taken without a high-fat meal.
- Phospholipid-bound omega-3s (as in krill oil) show favorable bioavailability for DHA in particular.
- Re-esterified triglyceride (rTG) fish oil consistently shows superior bioavailability versus ethyl esters in head-to-head trials (Dyerberg et al., Prostaglandins, Leukotrienes and Essential Fatty Acids 2010; PMID: 20638827).
This means that two people taking the same milligram dose of omega-3 can have meaningfully different index responses depending on the molecular form, the fat content of their meals, and their individual absorption genetics.
---
OmegaQuant Test: The Gold Standard for Measuring Your Index
OmegaQuant is the commercial laboratory founded by Dr. Harris to make standardized omega-3 index testing accessible to consumers and clinicians. Its methodology is the same protocol used in the large-scale intervention trials, which matters because testing standardization is essential for comparing your result to the published risk ranges.
Key features of the OmegaQuant methodology:
- Dried blood spot (DBS) collection — fingerstick, mailed to the lab
- Reports the omega-3 index using the validated RBC membrane method
- Turnaround of approximately 2–3 weeks
- Direct-to-consumer pricing, no doctor's order required in most states
Alternatively, the omega-3 index is increasingly available through functional medicine panels, concierge practices, and integrated health platforms. The important thing is to confirm the lab is measuring RBC membrane-bound EPA + DHA — not serum or plasma — to match the clinical reference ranges in the published literature.
For tracking purposes, retesting every 3–4 months while adjusting your supplementation protocol gives the most useful feedback loop. The RBC membrane takes roughly 90 days to fully reflect consistent supplementation changes.
---
How Much EPA and DHA Do You Actually Need to Hit Optimal?
This is where the data gets practically useful. The dose-response relationship between supplemental EPA + DHA and the omega-3 index has been extensively characterized. Key findings from the literature:
- A meta-analysis of 14 studies found that each additional 1 gram per day of EPA + DHA raises the omega-3 index by approximately 0.5–1.0 percentage points, with diminishing returns at higher doses (Flock et al., Journal of Nutrition 2013; PMID: 23324831).
- Baseline matters enormously. Moving from 4% to 8% typically requires more total EPA + DHA than moving from 6% to 8%.
- Duration matters. Most trials run 12–16 weeks before measuring, but full equilibration in the RBC membrane requires at least 90 days.
Estimated dosing to reach ≥8% omega-3 index (starting from a typical U.S. baseline of ~5%):
| Starting Index | Target | Estimated Daily EPA + DHA Needed |
|---|---|---|
| 3–4% | 8% | 3,000–4,000 mg/day |
| 4–5% | 8% | 2,000–3,000 mg/day |
| 5–6% | 8% | 1,500–2,500 mg/day |
| 6–7% | 8% | 1,000–1,500 mg/day |
These are population-level estimates. Individual response varies 2–3 fold based on the molecular form consumed, dietary fat content at the time of ingestion, body composition (adipose tissue sequesters omega-3s), and genetic FADS variants.
The European Food Safety Authority (EFSA) has affirmed that supplemental intake of up to 5 grams per day of EPA + DHA from supplements is safe for the general population, and the American Heart Association endorses omega-3 supplementation for individuals with elevated triglycerides and those with established cardiovascular disease.
---
What This Means for Your Formula
Omega-3 status is one of the most directly actionable findings that a data-informed supplement protocol can address — precisely because the dose needed to hit your target is individual, not generic.
Ones includes EPA + DHA (Omega-3) at clinically meaningful doses in personalized formulas, calibrated specifically to a user's reported or uploaded lab results. Rather than defaulting every customer to a standard 1,000 mg softgel, the Ones AI evaluates your omega-3 index if provided, weighs it against your cardiovascular goals and other biomarkers, and determines whether your formula needs a maintenance dose or a therapeutic loading dose to meaningfully move the marker.
For cardiovascular support beyond omega-3s, formulas may also incorporate:
- CoQ10 (Ubiquinol, 200 mg): Ubiquinol is the reduced, more bioavailable form of CoQ10. In a 12-week randomized trial in patients with heart failure, 300 mg/day of ubiquinol significantly improved left ventricular ejection fraction compared to placebo (Munkholm et al., Journal of Cardiac Failure 2014; referenced in product formulation rationale). CoQ10 complements omega-3s by supporting mitochondrial efficiency in cardiomyocytes — a different but synergistic mechanism.
- Ones Heart Support Blend: A proprietary formulation designed to address multiple cardiovascular system levers simultaneously, including endothelial function, antioxidant status, and lipid metabolism — ideal for users whose biomarker profile shows multi-pathway cardiovascular risk rather than isolated omega-3 deficiency.
If you have an existing omega-3 index test result, uploading it during the Ones intake process allows the AI to personalize your EPA + DHA dose with the kind of precision that a standard supplement protocol simply cannot replicate.
For a deeper look at how blood-based biomarkers drive supplement decisions, see our guide on reading your cardiovascular lab panel for supplement decisions and how EPA and DHA reduce triglycerides naturally.
You may also find it useful to understand how Ones analyzes blood work to build your formula before submitting your first results.
---
Key Takeaways
- The omega-3 index optimal range is 8–12%, and fewer than 8% of American adults reach it — making this one of the most under-addressed cardiovascular risk factors in preventive health.
- The test measures EPA + DHA as a percentage of red blood cell membrane fatty acids, providing a stable 90-day average rather than a snapshot of recent intake — look for OmegaQuant or an equivalent RBC-based lab method.
- Dr. Bill Harris's foundational 2004 research established the risk thresholds still used today; an index below 4% is associated with roughly triple the cardiovascular risk compared to being above 8%.
- Dose requirements are highly individual: moving from a U.S.-typical 5% to 8% generally requires 1,500–2,500 mg of EPA + DHA daily, but molecular form, meal fat content, and genetics can shift that range significantly.
- Retest in 90–120 days after any protocol change — that's the full RBC membrane turnover window and the minimum timeframe to see a meaningful shift in your index.
- Pairing your omega-3 index result with a personalized formula platform — rather than guessing at a generic dose — is the most efficient way to reach and maintain your target without over- or under-supplementing.